Cancer

Items 1-10 of 435

Page
per page
Set Descending Direction
  1. α-Galactosylceramide
    CAS  158021-47-7
    AG-CN2-0013
    AG-CN2-0013-C250250 µg
    CHF 130.00
    AG-CN2-0013-M0011 mg
    CHF 210.00
    AG-CN2-0013-M0055 mg
    CHF 840.00
    α-Galactosylceramide
  2. α-Galactosylceramide (Dansylated)
    CAS  424823-23-4
    AG-CN2-0514
    AG-CN2-0514-C500500 µg
    CHF 350.00
    AG-CN2-0514-M0011 mg
    CHF 590.00
    α-Galactosylceramide (Dansylated)
  3. α-Galactosylceramide Analog 8
    CAS  922727-14-8
    AG-CR1-3622
    AG-CR1-3622-C500500 µg
    CHF 290.00
    α-Galactosylceramide Analog 8
  4. β-Nicotinamide adenine dinucleotide hydrate
    CAS  53-84-9
    CDX-N0222
    CDX-N0222-G0011 g
    CHF 54.00
    CDX-N0222-G0055 g
    CHF 162.00
    CDX-N0222-G01010 g
    CHF 272.00
    β-Nicotinamide adenine dinucleotide hydrate
  5. β-Nicotinamide adenine dinucleotide phosphate
    CAS  698999-85-8
    CDX-N0151
    CDX-N0151-M500500 mg
    CHF 150.00
    CDX-N0151-G0011 g
    CHF 237.00
    β-Nicotinamide adenine dinucleotide phosphate
  6. (±)-Lisofylline
    CAS  6493-06-7
    CDX-H0117
    CDX-H0117-M01010 mg
    CHF 61.00
    CDX-H0117-M05050 mg
    CHF 204.00
    (±)-Lisofylline
  7. (±)-Naringenin
    CAS  67604-48-2
    CDX-N0206
    CDX-N0206-G0055 g
    CHF 61.00
    CDX-N0206-G02525 g
    CHF 150.00
    (±)-Naringenin
  8. (±)-Verapamil . hydrochloride (USP Grade)
    CAS  152-11-4
    AG-CR1-3627
    AG-CR1-3627-M100100 mg
    CHF 35.00
    AG-CR1-3627-G0011 g
    CHF 45.00
    AG-CR1-3627-G0055 g
    CHF 135.00
    (±)-Verapamil . hydrochloride (USP Grade)
  9. (+)-Catechin . hydrate
    CAS  225937-10-0 or 88191-48-4
    AG-CN2-0407
    AG-CN2-0407-M500500 mg
    CHF 40.00
    AG-CN2-0407-G0011 g
    CHF 65.00
    (+)-Catechin . hydrate
  10. (-)-Catechin
    CAS  18829-70-4
    CDX-C0453
    CDX-C0453-M0055 mg
    CHF 150.00
    CDX-C0453-M02525 mg
    CHF 597.00
    (-)-Catechin

Items 1-10 of 435

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.